Viewing Study NCT05568212

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-02-01 @ 7:10 AM
Study NCT ID: NCT05568212
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2022-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab
Sponsor: Fondazione Ricerca Traslazionale
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small-cell Lung Cancer Patients View
Keywords: